Koppert and Amoéba Partner on Innovative Biofungicide
Amoeba SA (FR:ALMIB) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Koppert, a leader in biological crop protection, and Amoéba, a greentech company, have signed a Memorandum of Understanding to jointly launch a groundbreaking biofungicide named AXPERA. This partnership aims to enhance sustainable agriculture by utilizing Amoéba’s innovative amoeba-based solution to combat fungal diseases. The collaboration will focus on distribution, production, and regulatory approvals, with AXPERA expected to hit the European market by the end of 2025.
For further insights into FR:ALMIB stock, check out TipRanks’ Stock Analysis page.
Trending Articles
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.